EVOLUTIONARY ORIGIN OF A KUNITZ-TYPE TRYPSIN-INHIBITOR DOMAIN INSERTED IN THE AMYLOID-BETA PRECURSOR PROTEIN OF ALZHEIMERS-DISEASE

被引:27
|
作者
IKEO, K
TAKAHASHI, K
GOJOBORI, T
机构
[1] NATL INST GENET, DNA RES CTR, MISHIMA, SHIZUOKA 411, JAPAN
[2] SHIMANE MED UNIV, DEPT PHYSIOL, IZUMO, SHIMANE 693, JAPAN
[3] GRAD UNIV ADV STUDIES, MISHIMA 411, JAPAN
关键词
SERINE PROTEASE INHIBITOR; KUNITZ TYPE; EVOLUTIONARY ORIGIN; ALZHEIMERS DISEASE; INSERTION SEQUENCE;
D O I
10.1007/BF00160466
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Kunitz-type protease inhibitor is one of the serine protease inhibitors. It is found in blood, saliva, and all tissues in mammals. Recently, a Kunitz-type sequence was found in the protein sequence of the amyloid-beta-precursor protein (beta-APP). It is known that beta-APP accumulates in the neuritic plaques and cerebrovascular deposits of patients with Alzheimer's disease. Collagen type VI in chicken also has an insertion of a Kunitz-type sequence. To elucidate the evolutionary origin of these insertion sequences, we constructed a phylogenetic tree by use of all the available sequences of Kunitz-type inhibitors. The tree shows that the ancestral gene of the Kunitz-type inhibitor appeared about 500 million years ago. Thereafter, this gene duplicated itself many times, and some of the duplicates were inserted into other protein-coding genes. During this process, the Kunitz-type sequence in the present beta-APP gene diverged from its ancestral gene about 270 million years ago and was inserted into the gene soon after duplication. Although the function of the insertion sequences is unknown, our molecular evolutionary analysis shows that these insertion sequences in beta-APP have an evolutionarily close relationship with the inter-alpha-trypsin inhibitor or trypstatin, which inhibits the activity of tryptase, a novel membrane-bound serine protease in human T4+ lymphocytes.
引用
收藏
页码:536 / 543
页数:8
相关论文
共 24 条
  • [21] SEQUENCING OF EXONS 16 AND 17 OF THE BETA-AMYLOID PRECURSOR PROTEIN GENE IN 14 FAMILIES WITH EARLY ONSET ALZHEIMERS-DISEASE FAILS TO REVEAL MUTATIONS IN THE BETA-AMYLOID SEQUENCE
    CRAWFORD, F
    HARDY, J
    MULLAN, M
    GOATE, A
    HUGHES, D
    FIDANI, L
    ROQUES, P
    ROSSOR, M
    CHARTIERHARLIN, MC
    NEUROSCIENCE LETTERS, 1991, 133 (01) : 1 - 2
  • [22] ANALYSIS AND QUANTITATION OF THE BETA-AMYLOID PRECURSOR PROTEIN IN THE CEREBROSPINAL-FLUID OF ALZHEIMERS-DISEASE PATIENTS WITH A MONOCLONAL ANTIBODY-BASED IMMUNOASSAY
    HENRIKSSON, T
    BARBOUR, RM
    BRAA, S
    WARD, P
    FRITZ, LC
    JOHNSONWOOD, K
    CHUNG, HD
    BURKE, W
    REINIKAINEN, KJ
    RIEKKINEN, P
    SCHENK, DB
    JOURNAL OF NEUROCHEMISTRY, 1991, 56 (03) : 1037 - 1042
  • [23] SCREENING FOR THE BETA-AMYLOID PRECURSOR PROTEIN MUTATION (APP717-VAL-]ILE) IN EXTENDED PEDIGREES WITH EARLY ONSET ALZHEIMERS-DISEASE
    CHARTIERHARLIN, MC
    CRAWFORD, F
    HAMANDI, K
    MULLAN, M
    GOATE, A
    HARDY, J
    BACKHOVENS, H
    MARTIN, JJ
    VAN BROECKHOVEN, C
    NEUROSCIENCE LETTERS, 1991, 129 (01) : 134 - 135
  • [24] INCREASED BETA-AMYLOID RELEASE AND LEVELS OF AMYLOID PRECURSOR PROTEIN (APP) IN FIBROBLAST CELL-LINES FROM FAMILY MEMBERS WITH THE SWEDISH ALZHEIMERS-DISEASE APP670/671 MUTATION
    JOHNSTON, JA
    COWBURN, RF
    NORGREN, S
    WIEHAGER, B
    VENIZELOS, N
    WINBLAD, B
    VIGOPELFREY, C
    SCHENK, D
    LANNFELT, L
    ONEILL, C
    FEBS LETTERS, 1994, 354 (03) : 274 - 278